Feed PCK.AX
PC

PainChek Limited

PCK.AX · ASX

$0.12 +4.55% (+$0.01)
1M +4.76%
Market Cap $24.0M
P/E Ratio -
Div. Yield -
ROE 1,578.34%
Piotroski F-Score Weak
2/9
Valuation
21 /100
Expensive
P/S 6.42x
P/FFO N/A
P/B N/A
Growth
100 /100
Growing
Rev. growth 24.28%
FCF growth N/A
Book val. growth N/A
Profitability
20 /100
Weak
Net margin 238.78%
Op. margin 264.97%
FCF margin 247.28%
Quality
6 /100
Poor
ROE 1,578.34%
ROA 117.14%
Asset turnover 0.49x
Debt
16 /100
High
Int. coverage -50.43x
Current ratio 0.99x
Net debt/EBITDA N/A
Stability
72 /100
Stable
Rev. volatility 12.92%
EPS volatility 10.67%
Profitable years 0

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Ask StockBot about PCK.AX
Online

Sector

Healthcare

Industry

Medical - Healthcare Information Services

CEO

Philip Daffas

Employees

25

Headquarters

Sydney

Upcoming events

03 MAR

Earnings

Upcoming earnings report

175d

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.